Lifera

Lifera is a biopharmaceutical company wholly owned by the Public Investment Fund (PIF) with a mission to enable two national priority objectives, which are improving Saudi Arabias biopharma resilience, and enabling the achievement of the National Biotech Strategy. To achieve this mission, Lifera aims to become a leading biopharma Contract Development and Manufacturing Organization (CDMO) with a focus on advanced therapeutics and critical medicines. Liferas strategy is to be a service provider to biopharma and biotech companies globally by developing and acquiring state-of-the-art cGMP biomanufacturing capacity, establishing high throughput multi-omics capacity to support clinical, population health and R&D customers, securing...

Biomanufacturing,vaccines,insulin,plasma therapeutics,sterile injectables,cell and gene therapy,plasmids,nucleic acids,multiomics,and genomic testing

Lifera operates in the Pharmaceutical manufacturing industry.

Lifera's revenue is 11m - 100m

Lifera has 11 - 50 employees.